PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1477914
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1477914
Robotic Endoscopy Devices Market - By Product Type (Diagnostic, Therapeutic), Application (Colonoscopy, Bronchoscopy, Laparoscopy, Gastroscopy), End-use (Hospitals, Ambulatory Surgical Centers) - Global Forecast, 2024 - 2032
Global Robotic Endoscopy Devices Industry will grow at 11% CAGR during 2024-2032, driven by the growing aging population demographics and changing lifestyle factors contributing to the rise in chronic conditions.
According to WHO, Noncommunicable diseases (NCDs) claim the lives of 41 million people annually, accounting for 74% of global deaths. As global populations age and lifestyles evolve, the incidence of chronic conditions such as diabetes, cardiovascular diseases, cancer, and respiratory ailments continues to rise. This demographic shift translates into heightened demand for innovative treatments, therapies, and preventive measures to manage these conditions effectively.
Consequently, the healthcare sector is experiencing a surge in R&D investments, leading to the discovery of novel drugs, medical devices, and digital health solutions tailored to address specific chronic diseases. Additionally, there is a growing emphasis on preventive healthcare initiatives, wellness programs, and lifestyle interventions aimed at reducing the risk factors associated with chronic illnesses. Moreover, technological breakthroughs, such as telemedicine, wearable devices, and health monitoring apps, are revolutionizing patient care and empowering individuals to actively manage their health.
The Robotic Endoscopy Devices Market is classified based on product type, application, end-use, and region.
The diagnostic robotic endoscopy devices segment will grow appreciably through 2032, owing to their ability to provide high-definition imaging, precise tissue sampling, and real-time visualization of internal organs. These devices help in the early detection and accurate diagnosis of various gastrointestinal and respiratory conditions, including ulcers, polyps, tumors, and inflammatory bowel diseases, thereby inducing segment growth.
The Robotic Endoscopy Devices Market share from the bronchoscopy segment will gain traction by 2032 due to the widespread use of bronchoscopy in diagnosing and treating respiratory disorders such as lung cancer, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Robotic bronchoscopy enables clinicians to navigate the intricate airway anatomy with enhanced maneuverability and dexterity, thus facilitating precise lesion localization, biopsy collection, and therapeutic interventions, thereby propelling segment expansion.
Asia Pacific Robotic Endoscopy Devices Industry is poised for substantial growth by 2032, driven by a rapidly expanding healthcare infrastructure, in line with increasing investments in medical technology. Additionally, the rising prevalence of respiratory diseases in countries such as China, India, and Japan is boosting the adoption of robotic endoscopy devices for both diagnostic and therapeutic purposes.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising incidences of gastrointestinal disorders and other chronic ailments
- 3.2.1.2 Increasing demand for minimally invasive procedures
- 3.2.1.3 Rise in prevalence of obesity and diabetes coupled with growing ageing population
- 3.2.1.4 Technological advancements in endoscopy
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Dearth of skilled physicians and endoscopists in developing countries
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
- 3.7 PESTEL analysis
- 3.8 Future market trends
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Diagnostic
- 5.3 Therapeutic
Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Colonoscopy
- 6.3 Bronchoscopy
- 6.4 Laparoscopy
- 6.5 Gastroscopy
- 6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ambulatory surgical centers
- 7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 AKTORmed GmbH
- 9.2 Asensus Surgical Inc.
- 9.3 Boston Scientific Corporation
- 9.4 Brainlab AG
- 9.5 CONMED Corporation
- 9.6 FUJIFILM Holdings Corporation
- 9.7 Intuitive Surgical, Inc.
- 9.8 Karl Storz SE & Co. KG
- 9.9 Medtronic plc
- 9.10 Olympus Corporation
- 9.11 Renishaw plc
- 9.12 Richard Wolf GmbH
